Sands Capital Ventures, LLC
Related Filers (3)
Other (12)
13F-HR
Tuesday, 2/13/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/12/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/13/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/9/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/12/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/13/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 1/21/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Friday, 11/12/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/4/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-NT
Wednesday, 2/17/2021
Initial Quarterly Form 13F Notice Report filed by institutional managers
Ownership (4)
SC 13G
Tuesday, 2/13/2024
Klaviyo, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/13/2024
Acrivon Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Acrivon Therapeutics, Inc.: Major Shareholders
SC 13G/A
Tuesday, 2/14/2023
Acumen Pharmaceuticals, Inc.: Major Shareholders